Human Genome Epidemiology Literature Finder
Records 1 - 11 (of 11 Records) |
Query Trace: Thrombosis and BCR[original query] |
---|
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis. Leukemia 2009 May 23 (5): 905-11. Tefferi A, Pardanani A, Lim K-H, Abdel-Wahab O, Lasho T L, Patel J, Gangat N, Finke C M, Schwager S, Mullally A, Li C-Y, Hanson C A, Mesa R, Bernard O, Delhommeau F, Vainchenker W, Gilliland D G, Levine R |
[JAK2V617F mutation in the patients with myeloproliferative disorder and its relation with clinical characteristics]. Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology 2011 Aug 19 (4): 916-20. Zhu Jun-Fang, Liu Yuan, Liu Pei, Jia Ming-Feng, Cheng Juan, Zhao |
JAK2 V617F mutation prevalence in myeloproliferative neoplasms in Pernambuco, Brazil. Genetic testing and molecular biomarkers 2012 Feb . Silva RR, Domingues Hatzlhofer BL, Machado CG, Lima AS, Albuquerque DM, Santos MN, Fertrin KY, Costa FF, Araújo AD, Bezerra MA |
[Detection and clinical significance of JAK2 V617F mutation in Chinese and Uyghur patients with chronic myeloproliferative in Xinjiang]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2012 Dec 33 (12): 12. Zhang XY, Maimaitili Y, Li Y, An L, Mao M, Fu L, Baier M, Wang XM |
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis. Leukemia research 2015 May 39 (5): 525-9. Gianelli Umberto, Iurlo Alessandra, Cattaneo Daniele, Bossi Anna, Cortinovis Ivan, Augello Claudia, Moro Alessia, Savi Federica, Castelli Roberto, Brambilla Cecilia, Bianchi Paola, Primignani Massimo, Cortelezzi Agostino, Bosari Silva |
Co-occurrence of Myeloproliferative Neoplasms and Solid Tumors Is Attributed to a Synergism Between Cytoreductive Therapy and the Common TERT Polymorphism rs2736100. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015 Oct . Krahling Tunde, Balassa Katalin, Kiss Katalin P, Bors Andras, Batai Arpad, Halm Gabriella, Egyed Miklos, Fekete Sandor, Remenyi Peter, Masszi Tamas, Tordai Attila, Andrikovics Hajnal |
Coexistence of JAK2 and CALR mutations and their clinical implications in patients with essential thrombocythemia. Oncotarget 2016 Jul . Min-Gu Kang, Hyun-Woo Choi, Jun Hyung Lee, Yong Jun Choi, Hyun-Jung Choi, Jong-Hee Shin, Soon-Pal Suh, Szardenings Michael, Hye-Ran Kim, Myung-Geun Sh |
Genetic Polymorphisms of Hemostatic Factors and Thrombotic Risk in Non BCR-ABL Myeloproliferative Neoplasms: A Pilot Study. Balkan journal of medical genetics : BJMG 2017 Jun 20 (1): 35-42. Dambrauskien? R, Gerbutavi?ius R, Ugenskien? R, Jankauskait? R, Savukaityt? A, Šimoli?nien? R, Rudžianskien? M, Gerbutavi?ien? R, Juozaityt? |
Association of JAK2V617F mutation with thrombosis in Indian patients with Philadelphia negative chronic myeloproliferative neoplasms. Indian journal of pathology & microbiology 2018 7 61 (3): 371-374. Singh Kanwaljeet, Sazawal Sudha, Chhikara Sunita, Mahapatra Manoranjan, Saxena Re |
Risk factors of thrombosis in a cohort of 206 patients with BCR-ABL1 negative myeloproliferative neoplasms. Neoplasma 2021 10 68 (6): 1341-1350. Aswad Mohamed Hussam, Kissova Jarmila, Ovesna Petra, Penka Mirosl |
Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms. Open life sciences 2023 2 18 (1): 20220545. Dambrauskien? R?ta, Gerbutavi?ius Rolandas, Rudžianskien? Milda, Paukštaitien? Renata, Vitkauskien? Astra, Skrodenien? Erika, Remeikien? Diana, Zaborien? Inga, Juozaityt? Elo |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 18, 2023
- Content source: